Quadrant Capital Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$12.6K Buy
2025
Q2
Sell
2025
Q1
$2.28K Sell
2024
Q4
$3.74K Buy
2024
Q3
$2.49K Sell
2024
Q2
$5.35K Hold
2024
Q1
$6.75K Sell
2023
Q4
$8.45K Sell
2023
Q3
$12.5K Buy
2023
Q2
$1.57K Hold
2023
Q1
$1.27K Sell
2022
Q4
$6.18K Buy
2022
Q3
$3K Sell
2022
Q2
$3K Sell
2022
Q1
$10K Buy
2021
Q2
Sell
2021
Q1
$1K Buy